LDH-L REAGENT
SET (Colorimetric, Endpoint
Procedure)
For the quantitative determination of lactate
dehydrogenase activity in serum.
INTRODUCTION
The enzyme lactate dehydrogenase (LDH-L) is
distributed in tissues particularly heart, liver, muscle, and kidney. The
enzyme found in circulation is a mixture of five isoenzymes based on their
mobility. Elevated serum levels of LDH-L are found in serum in myocardial
infraction, liver disease, renal disease, certain forms of anemia, malignant
diseases and progressive muscle dystrophy.1,2
Several colorimetric LDH-L assay method have been
developed. Most of these assays are based on the coupling of the reduction of NAD
and tetrazolium salts (INT). Nachlas, et al3, described an LDH-L
assay using phenazine methosulfate (PMS) as the intermediate electron carrier
between NADH and INT. Allain, et al4, replaced PMS with the enzyme diaphorase.
PRINCIPLE
LDH catalyzes the oxidation of lactate to pyruvate
in the presence of NAD which is subsequently reduced to NADH. The formation of
NADH is coupled with the reduction of INT to INTH catalyzed by the enzyme of
diaphorase. INTH is bright red formazan which is measured photometrically at
500 ± 5 nm. The color intensity is proportional to the LDH-L activity of the
sample.
REAGENT
COMPOSITION
LDH Substrate:
DL-Lactate 75 mM; NAD 5.5 mM, Diaphorase 5 u/ml. Buffer 80 mM; pH = 9.0 +
0.1 (30°C); Non-reactive stabilizers and fillers.
LDH Color Reagent: An aqueous solution containing
INT with preservative.
LDH Calibrator: A lyophilized serum with LDH value
provided in each lot. Reconstitute with 5 ml distilled water and swirl to mix.
Aliquot into small portions and keep frozen.
PRECAUTIONS
1. For
"in vitro" diagnostic use only.
2. Exercise
the normal precations required for the handling of all laboratory
reagents. Pipetting by mouth is
not recommended for any laboratory reagent.
REAGENT
PREPARATION
Reconstitute LDH sustrate reagent with volume of
distilled water stated on the vial label. Invert gently to dissolve.
REAGENT STORAGE
1. Store
reagent at 2 - 8°C.
2.
Reconstituted reagent is stable for seven (7) days when
refrigerated at 2 - 8°C and for eight (8) hours at room
temperature.
REAGENT
DETERIORATION
1. If the
reagent blank before serum addition exceeds 0.45 at 340
nm, the
reagent may have deteriorated.
2. Failure to
obtain accurate results in the assay of control materials
may
indicate reagent deterioration.
SPECIMEN
COLLECTION AND HANDLING
1. Serum with any visible hemolysis can not be
used because of the contamination of this sample with large amount of LDH-L
released from the erythrocytes.3
2. Serum should be separated from the clot
promptly.
3. Samples should be assayed soon after
collection. LDH-L in serum is reported stable for two to three days at room
temperature.2
4. The liver LDH-L is particularly labile and
is destroyed if frozen and thawed.5
INTERFERENCES
1. Oxalate, oxamates,
and EDTA will inhibit LDH-L.
2. Young, et
al., gave a list of drugs and other substances interfere
with the
determination of LDH-L activity.6
MATERIALS
PROVIDED
LDH-L substrate, LDH-L Color Reagent and LDH-L Calibrator.
MATERIALS
REQUIRED BUT NOT PROVIDED
1. Accurate
pipeting devices.
2. Test tubes
and rack.
3. Timer.
4. Heating
bath or block (37°C).
5. 0.1 N
Hydrochloric Acid.
PROCEDURE
(MANUAL, ENDPOINT)
1. Pipette
0.5 ml of LDH-substrate into vials labeled reagent blank, calibrator, control,
and unknown(s).
2. Add 0.1 ml (100 ml)
of LDH Color reagent to all vials, mix and prewarm at 37°C for three (3)
minutes.
3. At time intervlas, add 0.020 ml (20 ml)
of sample to its respective vial, mix and incubate at 37°C for exactly ten (10)
minutes.
4. Using the same timed interval sequence, add
2.0 ml of 0.1 N Hydrocloric acid to the reaction vials to stop the reaction.
Mix all tubes.
5. Set the
wavelength of the photometer at 500 nm and zero
instrument with reagent blank. Read and record
absorbance of
all vials.(Wavelength range:500-520).
* USE TC - MUTI PURPOSE CALIBRATOR TO
REPLACE STANDARD.
CALCULATION
Use the absorbance readings of the calibrator and
unknown(s) to
calculate LDH-L values as follows:
Absorbance
of Unknown x concentration of Calibrator
(IU/L) =
Absorbance
of Calibrator LDH in unknown
(IU/L).
Example of Calculation:
Assume that the calibrator has a concentration of 150
IU/L and that it gave an absorbance of 0.240, while the unknown gave an
absorbance of 0.350. The LDH concentration of the unknown may then be
calculated as follows:
0.350 x 150 IU/L = 218 IU/L.
0.240
PROCEDURE LIMITATION
1. The
procedure measures total lactic dehydrogenase irrespective
of its tissue or organ of origin.
2. The reaction temperature must be maintained
to within + 0.1 °C,
during the assay.
QUALITY CONTROL
It is recommended that controls be included in each
set of assays. Commercially available
control material with LDH-L values may be used for quality control. The
assigned value of the control material must be confirmed by the chosen
application. Failure to obtain the proper range of values in the assay of
control material may indicate either reagent deterioration, instrument
malfunction or procedural errors.
TEMPERATURE CORRECTION7
1. If the assay is performed at 37°C but is to
be reported at 30°C;
multiply the results by 0.6
Note:
Temperature factors give only an approximate conversion and
therefore it is suggested that values be reported at the
temperature of measurement.
EXPECTED VALUES7
Males 80
- 285 IU/L (37°C)
Females 103 - 227 IU/L (37°C)
It is strongly recommended. that each laboratory
establish its own normal range.
PERFORMANCE
1. Linearity: 800 IU/L
2. Comparison: Studies between the present
method and with an optimized LDH, UV method yield a correlation coefficient of
0.99 and a regression
equation of y = 1.00x (UV) +
3.71.
3. Precision studies.
Within
Run
Mean (mg/dl) S.D. C.V.%
145 9 6
387 18 5
Run
to Run
Mean(mg/dl) S.D. C.V.%
146 12 8
380 22 6
REFERENCES
1. Henry, J.B., Clinical
Diagnosis and Management by Laboratory Methods, W. B. Saunders and Company,
Philadelphia, PA p 365 (1979).
2. Tietz, R. W., Fundamentals of Clinical Chemistry, W.B.
3. Nachlas, M.N., et al., Anal.
Biochem 1:317 (1960).
4. Allain, C.C., et al., Clin. Chem., 19:223 (1973).
5. Kreutzer, H.H. et. at., Clin.
Chem., Acta 9:64 (1964).
6. Young, D.S., et at., Clin. Chem., 21:ID 432D (1975).
7. Henry, R.J. et al., Clinical
Chemistry; Principles and Techniques, 2nd Ed., Harper and Row, Hagerstown
(MD)
p 819-831 (1974).
Date
Revised: 6/95